Getting new, more effective drugs to market faster, more economically and safely is prompting innovative development strategies and business models to support successful outcomes for both investors and patients. To commercialize drugs efficiently, outsourcing has become an increasingly attractive business model for pharma, especially for small and medium companies.
In this white paper from Pfizer CentreOne, explore what influences pharmaceutical manufacturing strategy today and how the pharma industry can better leverage CMOs to facilitate success from the start.